FDA Okays Oral Formulation of Perampanel (Fycompa)

Perampanel (Fycompa) will now be available in oral suspension formulation for partial-onset seizures with or without secondary generalized seizures, as well as primary generalized tonic-clonic seizures for patients aged 12 years and older.